Karlheinz Peter

Professor

20032019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review Article
2018

Current and future antiplatelet therapies: Emphasis on preserving haemostasis

McFadyen, J. D., Schaff, M. & Peter, K., 1 Mar 2018, In : Nature Reviews Cardiology. 15, 3, p. 181-191 11 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

39 Citations (Scopus)
2017

Cytotoxic lymphocytes and atherosclerosis: Significance, mechanisms and therapeutic challenges

Kyaw, T., Peter, K., Li, Y., Tipping, P., Toh, B. H. & Bobik, A., Nov 2017, In : British Journal of Pharmacology. 174, 22, p. 3956–3972 17 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

8 Citations (Scopus)

Novel antithrombotic drugs on the Horizon: The ultimate promise to prevent clotting while avoiding bleeding

McFadyen, J. D. & Peter, K., 1 Jan 2017, In : Circulation Research. 121, 10, p. 1133-1135 3 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

9 Citations (Scopus)

Platelet-Derived Microvesicles in Cardiovascular Diseases

Zaldivia, M. T. K., McFadyen, J. D., Lim, B., Wang, X. & Peter, K., 21 Nov 2017, In : Frontiers in Cardiovascular Medicine. 4, 13 p., 74.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File

The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases

Ta, H. T., Truong, N. P., Whittaker, A. K., Davis, T. P. & Peter, K., 2017, In : Expert Opinion on Drug Delivery. 15, 1, p. 33-45 13 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

22 Citations (Scopus)
2013

Destination known: Targeted drug delivery in atherosclerosis and thrombosis

Westein, E., Flierl, U., Hagemeyer, C. E. & Peter, K., 2013, In : Drug Development Research. 74, 7, p. 460-471 12 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

16 Citations (Scopus)
2012

Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.

Ahrens, I., Peter, K., Lip, G. Y. H. & Bode, C., Jun 2012, In : Discovery Medicine. 13, 73, p. 433-443 11 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

12 Citations (Scopus)

Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.

Ahrens, I., Peter, K., Lip, G. Y. H. & Bode, C., Jun 2012, In : Discovery Medicine. 13, 73, p. 445-450 6 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

27 Citations (Scopus)

Enzymatic antibody tagging: Toward a universal biocompatible targeting tool

Ta, H. T., Peter, K. & Hagemeyer, C. E., May 2012, In : Trends in Cardiovascular Medicine. 22, 4, p. 105-111 7 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

18 Citations (Scopus)
2011

Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy

Fernando, H., Dart, A. M., Peter, K. & Shaw, J. A., Jun 2011, In : Thrombosis and Haemostasis. 105, 6, p. 933-944 12 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

38 Citations (Scopus)
2007

Single-chain antibodies as new antithrombotic drugs

Hagemeyer, C. E., Schwarz, M. & Peter, K., Mar 2007, In : Seminars in Thrombosis and Hemostasis. 33, 2, p. 185-195 11 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

13 Citations (Scopus)